MD Pediatrix Medical Group, Inc.

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: provider of neonatal and pediatric healthcare services
• • No new products, services, or segments introduced or emphasized this year
• • No stated strategic shift or changed competitive positioning vs prior year
• • 144 holders of record of common stock as of February 13, 2026; stock price $21.52 per share
• • No dividends declared or paid in 2023-2025; dividend payments limited by credit agreement

Risk Factors

• • Regulatory/legal risk: potential audit, inquiry, or investigation impact on revenue from government agencies over $1.15B gross receivables and DSO 42.8 days
• • Geopolitical/macro risk: 32% of net revenue concentrated in Texas exposing Pediatrix to regional health policy or economic shifts
• • Operational/supply chain risk: transformation and restructuring expenses $22.3M in 2025 due to shared services position eliminations and revenue cycle transitions
• • Competitive/market disruption risk: practice dispositions reducing net revenue by $99.1M or 4.9% in 2025, affecting market footprint and growth
• • Financial/structural risk: goodwill impairment charge of $150.6M in 2024 reflecting valuation sensitivity to market capitalization and stock price declines

Management Discussion & Analysis

• • Revenue details and YoY change not disclosed in provided text
• • Profitability or margin changes not specified in provided text
• • Segment details: 1,350 neonatal physicians, 475 maternal-fetal, 230 pediatric intensive care, 220 hospital-based pediatric, 20 pediatric surgical
• • No cash flow, buybacks, dividends, or capex info given
• • Risks: potential revenue impact from shifts toward government healthcare programs due to economic/demographic changes and rising bad debt from patient payment difficulties

What are the latest MD SEC filings in 2026?

Pediatrix Medical Group, Inc. (MD) has filed a 10-K annual report on February 19, 2026, a 10-Q quarterly report on May 5, 2026, an 8-K current report on August 4, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did MD file its most recent 10-K annual report?

Pediatrix Medical Group, Inc. (MD) filed its most recent 10-K annual report on February 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view MD 10-Q quarterly reports?

Pediatrix Medical Group, Inc. (MD)'s most recent 10-Q quarterly report was filed on May 5, 2026. SignalX displays every MD 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has MD filed recently?

Pediatrix Medical Group, Inc. (MD)'s most recent 8-K was filed on August 4, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find MD insider trading activity (Form 4)?

SignalX aggregates every MD Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does MD file with the SEC?

Pediatrix Medical Group, Inc. (MD) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new MD filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Pediatrix Medical Group, Inc. (MD).

What is MD's SEC CIK number?

Pediatrix Medical Group, Inc. (MD)'s SEC CIK (Central Index Key) number is 893949. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 893949 to look up all MD filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find MD return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Pediatrix Medical Group, Inc. (MD) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.